UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Pazopanib (GW786034) and cyclophosphamide in patients with platinum-resistant, recurrent, pre-treated ovarian cancer - Results of the PACOVAR-trial

Gynecologic oncology, 2017-08, Vol.146 (2), p.279-284

2017

Volltextzugriff (PDF)

Adjuvant chemotherapy in elderly patients with primary breast cancer: are women ≥65 undertreated?

Journal of cancer research and clinical oncology, 2016-08, Vol.142 (8), p.1847-1853

2016

Volltextzugriff (PDF)

Expression of the embryonic stem cell marker SOX2 in early-stage breast carcinoma

BMC cancer, 2011-01, Vol.11 (1), p.42-42, Article 42

2011

Volltextzugriff (PDF)

Synchronous Endometrial and Ovarian Carcinomas: Evidence of Clonality

JNCI : Journal of the National Cancer Institute, 2016-06, Vol.108 (6), p.djv428-djv428

2016

Volltextzugriff (PDF)

Influence of patient and tumor characteristics on therapy persistence with letrozole in postmenopausal women with advanced breast cancer: results of the prospective observational EvAluate-TM study

BMC cancer, 2019-06, Vol.19 (1), p.611-611, Article 611

2019

Volltextzugriff (PDF)

Estrogen, progesterone, and human epidermal growth factor receptor 2 discordance between primary and metastatic breast cancer

Breast cancer research and treatment, 2020-08, Vol.183 (1), p.137-144

2020

Volltextzugriff (PDF)

Bisphosphonate-induced osteonecrosis of the jaw (ONJ): Incidence and risk factors in patients with breast cancer and gynecological malignancies

Gynecologic oncology, 2009-03, Vol.112 (3), p.605-609

2009

Volltextzugriff (PDF)

Final analysis of the prospective WSG-AGO EC-Doc versus FEC phase III trial in intermediate-risk (pN1) early breast cancer: efficacy and predictive value of Ki67 expression

Annals of oncology, 2014-08, Vol.25 (8), p.1551-1557

2014

Volltextzugriff (PDF)

Higher efficacy of letrozole in combination with trastuzumab compared to letrozole monotherapy as first-line treatment in patients with HER2-positive, hormone-receptor-positive metastatic breast cancer – Results of the eLEcTRA trial

Breast (Edinburgh), 2012-02, Vol.21 (1), p.27-33

2012

Volltextzugriff (PDF)

Time trends of neoadjuvant chemotherapy for early breast cancer

International journal of cancer, 2020-12, Vol.147 (11), p.3049-3058

2020

Volltextzugriff (PDF)

Influence of patient and tumor characteristics on early therapy persistence with letrozole in postmenopausal women with early breast cancer: results of the prospective Evaluate-TM study with 3941 patients

Annals of oncology, 2018-01, Vol.29 (1), p.186-192

2018

Volltextzugriff (PDF)

COMPliance and Arthralgia in Clinical Therapy: the COMPACT trial, assessing the incidence of arthralgia, and compliance within the first year of adjuvant anastrozole therapy

Annals of oncology, 2014-02, Vol.25 (2), p.372-377

2014

Volltextzugriff (PDF)

Use of complementary and integrative medicine among German breast cancer patients: predictors and implications for patient care within the PRAEGNANT study network

Archives of gynecology and obstetrics, 2017-05, Vol.295 (5), p.1239-1245

2017

Volltextzugriff (PDF)

Impact of apoptotic circulating tumor cells (aCTC) in metastatic breast cancer

Breast cancer research and treatment, 2016-11, Vol.160 (2), p.277-290

2016

Volltextzugriff (PDF)

Comparison of prognostic and predictive impact of genomic or central grade and immunohistochemical subtypes or IHC4 in HR+/HER2- early breast cancer: WSG-AGO EC-Doc Trial

Annals of oncology, 2016-06, Vol.27 (6), p.1035-1040

2016

Volltextzugriff (PDF)

Receptor change-clinicopathologic analysis of matched pairs of primary and cerebral metastatic breast cancer

Journal of cancer research and clinical oncology, 2013-11, Vol.139 (11), p.1909-1916

2013

Volltextzugriff (PDF)

CNS metastases of breast cancer show discordant immunohistochemical phenotype compared to primary

Journal of cancer research and clinical oncology, 2013-04, Vol.139 (4), p.551-556

2013

Volltextzugriff (PDF)

Ten-year results of intense dose-dense chemotherapy show superior survival compared with a conventional schedule in high-risk primary breast cancer: final results of AGO phase III iddEPC trial

Annals of oncology, 2018-01, Vol.29 (1), p.178-185

2018

Volltextzugriff (PDF)

Selective microdochectomy after ductoscopic wire marking in women with pathological nipple discharge

BMC cancer, 2009-05, Vol.9 (151), p.151-151, Article 151

2009

Volltextzugriff (PDF)

Breast cancer patients' expectations in respect of the physician–patient relationship and treatment management results of a survey of 617 patients

Annals of oncology, 2007-03, Vol.18 (3), p.479-484

2007

Volltextzugriff (PDF)

Interest in Integrative Medicine Among Postmenopausal Hormone Receptor–Positive Breast Cancer Patients in the EvAluate-TM Study

Integrative cancer therapies, 2017-06, Vol.16 (2), p.165-175

2017

Volltextzugriff (PDF)

Salvage chemotherapy for metastatic breast cancer: results of a phase II study with bendamustine

Annals of oncology, 2007-12, Vol.18 (12), p.1981-1984

2007

Volltextzugriff (PDF)

Impaired Bone Microenvironment: Correlation between Bone Density and Presence of Disseminated Tumor Cells

Anticancer research, 2011-12, Vol.31 (12), p.4423-4428

2011

Volltextzugriff (PDF)

Disseminated tumor cells are not associated with established risk factors, L1CAM immunoreactivity and outcome in endometrial carcinoma

Journal of cancer research and clinical oncology, 2017-11, Vol.143 (11), p.2183-2188

2017

Volltextzugriff (PDF)

Nodal status—its impact on prognosis in advanced ovarian cancer

Journal of cancer research and clinical oncology, 2012-02, Vol.138 (2), p.261-267

2012

Volltextzugriff (PDF)

1 – 25 von 31

Suche als RSS-Feed

Aktive Filter

ThemaAged

ThemaOncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(31)
Mit Volltextzugriff
(28)

Publikationsform

Artikel
(31)

Sprache

Englisch
(31)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

13 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Pazopanib (GW786034) and cyclophosphamide in patients with platinum-resistant, recurrent, pre-treated ovarian cancer - Results of the PACOVAR-trial

Adjuvant chemotherapy in elderly patients with primary breast cancer: are women ≥65 undertreated?

Expression of the embryonic stem cell marker SOX2 in early-stage breast carcinoma

Synchronous Endometrial and Ovarian Carcinomas: Evidence of Clonality

Influence of patient and tumor characteristics on therapy persistence with letrozole in postmenopausal women with advanced breast cancer: results of the prospective observational EvAluate-TM study

Estrogen, progesterone, and human epidermal growth factor receptor 2 discordance between primary and metastatic breast cancer

Bisphosphonate-induced osteonecrosis of the jaw (ONJ): Incidence and risk factors in patients with breast cancer and gynecological malignancies

Final analysis of the prospective WSG-AGO EC-Doc versus FEC phase III trial in intermediate-risk (pN1) early breast cancer: efficacy and predictive value of Ki67 expression

Higher efficacy of letrozole in combination with trastuzumab compared to letrozole monotherapy as first-line treatment in patients with HER2-positive, hormone-receptor-positive metastatic breast cancer – Results of the eLEcTRA trial

Time trends of neoadjuvant chemotherapy for early breast cancer

Influence of patient and tumor characteristics on early therapy persistence with letrozole in postmenopausal women with early breast cancer: results of the prospective Evaluate-TM study with 3941 patients

COMPliance and Arthralgia in Clinical Therapy: the COMPACT trial, assessing the incidence of arthralgia, and compliance within the first year of adjuvant anastrozole therapy

Use of complementary and integrative medicine among German breast cancer patients: predictors and implications for patient care within the PRAEGNANT study network

Impact of apoptotic circulating tumor cells (aCTC) in metastatic breast cancer

Comparison of prognostic and predictive impact of genomic or central grade and immunohistochemical subtypes or IHC4 in HR+/HER2- early breast cancer: WSG-AGO EC-Doc Trial

Receptor change-clinicopathologic analysis of matched pairs of primary and cerebral metastatic breast cancer

CNS metastases of breast cancer show discordant immunohistochemical phenotype compared to primary

Ten-year results of intense dose-dense chemotherapy show superior survival compared with a conventional schedule in high-risk primary breast cancer: final results of AGO phase III iddEPC trial

Selective microdochectomy after ductoscopic wire marking in women with pathological nipple discharge

Breast cancer patients' expectations in respect of the physician–patient relationship and treatment management results of a survey of 617 patients

Interest in Integrative Medicine Among Postmenopausal Hormone Receptor–Positive Breast Cancer Patients in the EvAluate-TM Study

Salvage chemotherapy for metastatic breast cancer: results of a phase II study with bendamustine

Impaired Bone Microenvironment: Correlation between Bone Density and Presence of Disseminated Tumor Cells

Disseminated tumor cells are not associated with established risk factors, L1CAM immunoreactivity and outcome in endometrial carcinoma

Nodal status—its impact on prognosis in advanced ovarian cancer

Aktive Filter

Suchergebnisse filtern